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Abstract: We determined the effect of a GnRH vaccine on reproductive function of sexually 
mature 5-month female and male domestic swine. The vaccine, GonaConTM, developed at 
NWRC contains a GnRH peptide conjugated to KLH, combined with AdjuVacTM adjuvant also 
developed at NWRC.  Four groups of ten females were given single IM immunizations either of 
800µg GnRH vaccine, 1600µg GnRH vaccine, a prime and boost of 400µg GnRH vaccine and a 
sham dose adjuvant alone (control). At 8 months old, females were evaluated daily for estrus and 
bred by artificial insemination if in standing heat. Females not showing heat after 60 days were 
considered infertile. Farrowing data were collected for bred females ~115days later. All control 
gilts showed heat and became pregnant, whereas none given the dual 400µg dose showed heat or 
were bred. Of the 10 gilts receiving 800µg GnRH vaccine 3 were bred, but only 2 became 
pregnant. For gilts receiving 1600µg, 1 showed heat and became pregnant. Serum antibody titers 
were non-detectable in the control group, highest in gilts receiving 2×-400µg, followed by 
1600µg and 800µg treatments. Titers were inversely correlated to suppression of estrus and 
fertility. Groups of five boars received either adjuvant only, 1×- 800µg or 1600µg, or 2×- 400µg 
GnRH vaccine IM. Blood and scrotal testicular measurements were taken initially and 4 and 
16week post-treatment. Testicular size and serum testosterone decreased in all groups except 
controls and was inversely related to serum antibody titers. The authors conclude that; injectable 
GnRH vaccine is effective for contraception of swine.  
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INTRODUCTION 
 The population of feral swine in the 
U.S. now exceeds 2 million animals.  At 
least 26 states now have feral swine 
populations.  Endemic in most of these 
populations are the diseases pseudorabies 
and brucellosis.  With the near eradication of 
both of these diseases in domestic swine, 
their presence in feral swine places at risk 
the   local   domestic   populations   and   has  
 
become an important issue.  Research 
needed to address the feral swine disease 
issues includes development of safe, more 
efficacious oral vaccines and vaccine 
delivery systems as well as the development 
of more effective population control 
methods. The development of an 
efficacious, administered immuno-
contraceptive vaccine for feral swine would 
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be a valuable tool for use in disease 
management of pseudorabies and brucellosis 
(Rhyan and Drew 2002).   
 As part of the program to develop 
contraceptive tools to control populations of 
over-abundant wildlife species, the NWRC 
has researched the PZP and the GnRH 
contraceptive vaccines (Miller and 
Fagerstone 2000).  We found that PZP in 
white-tailed deer effectively contracepted 
the deer, however the deer experienced 
multiple estrus cycles many times into 
February (Miller et al. 1999, Killian and 
Miller 2000) Our first study using the GnRH 
vaccine was in the Norway rat (Miller et al. 
1997).  The rats remained contracepted 
throughout their short life.  We then tested 
the GnRH vaccine in white-tailed deer with 
good success. (Miller et al. 2000).  We are 
currently testing a newly developed single 
shot vaccine in white-tailed deer with good 
success.  
 Immunization against the GnRH 
hormone prevents the circulating GnRH 
from stimulating the release of pituitary LH 
and FSH.  In order to successfully neutralize 
GnRH, high titers of specific anti-GnRH 
antibody must be present to complex with 
the hormone and prevent it from binding to 
pituitary receptors. Immuno-neutralization 
of GnRH produces a temporary non-surgical 
castration in animals (Meloen  et al. 1994, 
Oonk et al. 1998). 
 To determine if a single-shot GnRH 
vaccine would be effective for contraception 
of feral swine, we used domestic swine to 
determine vaccine dosage and duration of 
the contraceptive effect. Zeng has recently 
tested a vaccine design in Chinese male pigs 
(Zeng et al. 2002).  
 
THE SINGLE SHOT VACCINE 
 Development of immunocon-
traceptives that are practical to use for 
wildlife population control must consider 
how the vaccine can be delivered. While 
administration of an oral form of the vaccine 
may be the ultimate goal, a long acting 
single-shot injectable form of the vaccine 
would also have practical advantages over 
the prime and boost vaccines currently in 
use. 
 Immunocontraception has typically 
required at least two doses, given as a prime 
and a boost.  The prime dose prepares the 
immune system for a repeat antigen 
exposure and provides only a short term 
immune response.    The boost 
immunization can result in an immune 
response which may last for months to 
years. Literature reports on antigen structure 
and retention have guided our efforts to 
produce a vaccine that is effective with one 
injection.  (Burton et al. 1994) have pointed 
out that the long-lasting immune response 
needed for immunocontraception is 
accomplished with “retained antigen.” 
Without a continued release of antigen (in 
this case KLH-GnRH), the immune response 
will decrease and the contraceptive effect 
with cease. Therefore, the antigen should 
remain in the host for a sufficient period so 
that immune-complexes are formed from 
antigen and specific antibody stimulated by 
the vaccine.  In the boost response, specific 
antibody is rapidly produced and binds with 
antigen producing immune-complexes (IC).  
The immune complexes (IC) formed from 
the combination of antigen and antibody are 
transported into the draining lymph node 
where the vast majority of the IC’s are 
eliminated by phagocytic cells.  However, a 
small portion of complexes are trapped on 
the surface of follicular dendritic cells 
(FDC) in the micro environment of the 
draining lymph node. 
 The FDC-mediated pathway of 
antigen handling is responsible for the 
induction and maintenance of long-term 
antibody response.  FDCs trap ICs and retain 
picogram amounts of antigen contained in 
the lymph nodes for long periods of time, 
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making intact antigen available to the 
immune system for months to years. 
Binding of the antigen to the antibody 
protects the conformation of the antigen, 
ensuring continued presence of the original 
antigen conformation. 
 Optimal vaccine design should create 
an immunogen that mimics pathogenic 
bacteria. Many pathogens, including viruses 
and bacteria, exhibit rigid, highly organized, 
highly repetitive protein epitopes. This 
repetitive epitope pattern provides a cross- 
linking activation of B cell receptors 
providing an extremely strong long-lasting 
immune response (Bachman  et al. 1993, 
Bachman and Zindernagel 1996).  This 
mimic of the repetitive nature of pathogen 
epitopes was an important part the KLH-
GnRH conjugate design for our vaccine.  
Banatvala et al. (2001) proposed that the 
antigen dose and structure influence the 
magnitude of the primary response.  The 
greater the primary response, the longer the 
duration of the immune memory. To have 
success with a single injection, the dose and 
the timing of the injection is more critical 
than that of a two shot.  
  We have observed that the adjuvant 
portion of the vaccine is critical to the 
success of the vaccine (Cooper 1994). The 
new KLH/GnRH vaccine we developed uses 
an adjuvant developed at the NWRC 
containing a modified USDA-approved 
Johne’s vaccine, Mycopar™, as a 
replacement for Freund’s adjuvant. Mycopar 
is approved for use in food animals and 
should not be a concern for use in deer or 
pigs, which may be eaten by hunters. The 
new adjuvant, which we have labeled 
AdjuVac™, contains a small quantity of 
Mycobacterium avium bacteria to which 
wildlife and domestic animals are 
commonly exposed. 
   This paper reports on 
immunocontraception of both female and 
male domestic pigs using the newly 
developed, single shot GnRH vaccine which 
has a USDA, APHIS patent pending status.  
  
METHODS 
 
Female Pigs 
 Forty 5-month-old gilts, held at the 
swine facility at Penn State University, were 
divided into groups of 10 each.  The groups 
were given doses of KLH/GnRH/AdjuVac 
vaccine as follows: 
1. GnRH (800µg) prime only 
2. GnRH (1600µg) prime only 
3. GnRH (400µg/400µg) prime and 
boost 
4. Control AdjuVac only 
 Groups were bled and given the 
primary vaccination in late October 2001.  
All groups were again bled and Group 3 
boosted in December.  During January/ 
February gilts were bled once and teased 
daily with a boar.  Gilts that showed heat 
were bred by artificial insemination (AI). 
Blood serum was collected and tested for 
anti-GnRH by ELISA and progesterone by 
RIA.  Infertile gilts (not showing heat) were 
put on pasture in March. 
 
 Male Pigs   
 Four groups of 5 adult male pigs were 
given doses of KLH/GnRH/AdjuVac 
vaccine as follows: 
1. IM GnRH (800µg) prime only 
2. IM GnRH (1600µg) prime only 
3. IM GnRH (400µg/400µg) prime 
and boost. 
4. Control  
 All pigs were pre-bled prior to 
vaccination and primed in May.  All groups 
were bled in June and Group 3 was given a 
boost injection. Serum collected during the 
bleeds was tested for anti-GnRH titers by 
ELISA and testosterone by RIA.  Body 
weights were measured throughout the study 
and testis and epididymis weights were 
taken at slaughter.  
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RESULTS 
 All groups of treated females and 
males produced an antibody response to the 
GnRH vaccine in a dose-related manner.  
Tables 1 and 4 show the means and ranges 
of antibody titers in the female and male 
groups.  The immune response of females 
was greater than that observed for the males. 
For the 800µg single dose, the mean 
antibody response was 28k in the male and 
70k in the female, and 80% of the females 
were infertile (Tables 2 and 3). The maximal 
response of 100% contraception was seen 
with the two shot injection regimen using a 
400µg prime and 400µg boost (Table 2).  
However, the 1600µg single shot 
contracepted 90% of the females, indicating 
the response of the single shot vaccine can 
approach the maximum response seen with 
the two shot. 
  
______________________________________________________________________________ 
 
Table 1.  Mean and range of GnRH antibody at the January breeding for females. 
______________________________________________________________________________ 
 
    Mean x 1000     Range 
 
 Control       0     0 
 800µg      70     16-128 
 1600µg   134     32-256 
 400/µg 400µg   208     64-256 
______________________________________________________________________________ 
______________________________________________________________________________ 
 
Table 2.   Percentage contraception in each group of females. 
______________________________________________________________________________ 
 
 Control       0 
 800µg      80 
 1600µg     90 
 400µg/400µg   100 
______________________________________________________________________________ 
______________________________________________________________________________ 
 
Table 3.  Farrowing data for females. 
_____________________________________________________________________________ 
 
 Control                n =10    105 pigs/10.5 pigs/litter 
 800µg       n =2      19 pigs/9.5 pigs/litter 
 1600µg     n =1        5 pigs/5 pigs/litter 
 400µg/400µg      n =0        0 pigs 
 Those gilts not pregnant were pastured for re-evaluation in a second breeding 
 ______________________________________________________________________________ 
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_____________________________________________________________________________ 
 
Table 4.   Mean and range of GnRH antibody at 3.5 months after vaccination for males. 
______________________________________________________________________________ 
 
     Mean x1000   Range x1000  
 Control       0    0 
 800µg      28    16-128 
 1600µg   130    32-128 
 400µg/400µg   102    32-128 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
 
Table 5.  Mean testosterone of males at the start of the study and after 3.5 months.  
______________________________________________________________________________ 
    Start     3.5 months     
    µg/100ml   µg/100ml 
  
 Control  147    202 
 800µg   180    162 
 1600µg  185    167 
 400/µg/400µg  208      52 
______________________________________________________________________________ 
______________________________________________________________________________ 
 
Table 6. Mean testis weight (grams) of males at 3.5 months.  L=Left, R=Right. 
______________________________________________________________________________ 
 
 Control     L 421 R 398 
 800µg   L 291 R 318 
 1600µg  L 247  R 256 
 400µg/400µg  L 177 R 194 
______________________________________________________________________________ 
______________________________________________________________________________ 
 
Table 7.  Mean body weight (lb) of males at start of study and at 3.5 months. 
______________________________________________________________________________ 
   Start    3.5 months 
 
Control  272    354 
800µg   254    352 
1600µg  269    353 
400µg/400µg  256    345 
_____________________________________________________________________________ 
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 Litter size of the control pigs 
averaged 10.5 pigs (Table 3), which was 
greater than that seen in the 800µg and 
1600µg treated females, averaging 9.5 pigs 
and 5 pigs per litter, respectively.  Because 
the two-shot dose was 100% effective, there 
were no litters produced. Although with 
only 1 litter produced in the group receiving 
the 1600 dose it is difficult to come to a 
definitive conclusion, it is possible that 
partial GnRH contraception may have 
reduced litter size. A reduction in litter size 
is possible if high titers of GnRH antibody 
reduce the number of multiple ovulations 
characteristic of swine. Alternatively, if 
ovulation does occur, GnRH antibodies 
could reduce GnRH stimulation of LH 
secretion for normal corpus luteum 
maintenance. This in turn may result in 
lower progesterone to maintain pregnancies 
with normal numbers of embryos.  
 In the control male pigs, testosterone 
increased with age (Table 5).  The two 
single-shot pig groups demonstrate a 
consistent reduction in testosterone by the 
end of the study, compared to the increased 
testosterone with increased age observed in 
the controls.  The reduction in testosterone 
in the 2-shot group is striking.   Testicular 
size (Table 6) and serum testosterone 
decreased in all groups except controls and 
was inversely related to serum antibody 
titers.    
 There was no affect of treatment on 
weight gain throughout the study among the 
control and treated groups (Table 7). 
Average body weights of all groups 
increased by 34%, regardless of treatment. 
 
DISCUSSION 
 The NWRC initiated research on the 
GnRH vaccine because immuno-
contraceptive porcine zona pellucida (PZP) 
vaccine used for deer produced a side effect 
of repeated estrous cycles (Miller et al. 
1999).  A practical concern was that large 
scale field use of the PZP vaccine would 
increase car-deer collisions as a result of 
increased breeding activity and an extended 
breeding season.  Most previously-tested 
GnRH vaccines have reported a short-lasting 
immune response and required multiple 
injections to provide a long-lasting immune 
response. Because the characteristics of 
these GnRH vaccines made them 
impractical to use for the contraception of 
wildlife, we began research to develop a 
single-shot GnRH vaccine with an adequate 
immune response. 
 In addition to pigs, this vaccine has 
been tested in rodents, deer, bison, wild 
horses, cats and dogs.  In each case the 
vaccine proved effective in reducing 
concentrations of sexual hormones and 
reproductive activity of the injected animal 
for at least one to two years with a single 
injection and several years with 2 injections.  
Contraception with the GnRH vaccine in 
females has been more effective than that 
found in males. This is likely related to the 
differences in GnRH and gonadotropin 
secretion patterns (cyclic versus steady) 
between females and males. If the monthly 
LH spike in the female is reduced, and 
infertility has been induced. The constant 
LH demand in the male produces a greater 
demand on the anti-GnRH antibody.  It also 
may be easier to shut down a seasonal 
animal such as the deer, compared to the pig 
which can breed year around.   
 This single shot GnRH vaccine was 
first tested in white-tailed deer at the 
Pennsylvania State University Deer 
Research Center. During the first year, the 
vaccine induced 100% infertility in both 
males and females, totally shutting down 
testosterone to a non-detectable level in all 
males tested.  In this study GnRH vaccine in 
the female demonstrated a dose relationship 
in number of heats experienced and 
farrowing rates, with the 800µg and 1600µg 
achieving an 80% and 90% reduction in 
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fertility, respectively.  However, only the 2 
shot dose achieved 100% reduction in 
fertility.  These data show the importance in 
testing the effectiveness of 
immunocontraceptive vaccines in each 
target species.   
 The effectiveness of the GnRH 
vaccine in deer and swine was different.  
Deer were injected in July while in a 
sexually dormant condition.  The GnRH 
vaccine induced an antibody titer that was 
present prior to and during the fall season 
when endogenous GnRH production was 
peaked.  The GnRH antibodies present 
prevented both sexes from developing the 
normal fall rut activity. In the female pig, 
hormonal activity fluctuates with the estrous 
cycle (Schneider et al. 1998, Zeng et al. 
2002). Immuno-inactivation of GnRH 
activity prevents stimulation of the LH pulse 
and inhibits heat and conception.  In 
contrast, the male pig has a non-pulsatile 
secretion of GnRH and a relatively steady 
secretion pattern of testosterone. 
Consequently, because GnRH secretion is 
relatively constant in the male, it is likely 
that higher titers of GnRH antibody are 
required to inactivate endogenous GnRH. 
 A second possibility for the higher 
vaccine dose required for female and male 
pigs is that some of the vaccine injected may 
be absorbed in the pig fat. Dr. Robert Brown 
from ImmunoVaccine Technologies 
(personal communication) has experienced 
this when injecting seals and possibly also in 
black bears.  Vaccine trapped in fat may not 
be released to the immune system, and 
therefore may be unavailable to induce an 
immune response. 
 
SUMMARY 
 The single-shot GnRH vaccine 
reduced the fertility of female domestic pigs 
in a dose related manner.  The vaccine also 
reduced  plasma testosterone and testicular 
size of intact boars.  The high-dose single-
shot vaccine produced results similar to that 
of the 2-shot vaccine in the female. In boars, 
the single shot 800 µg and 1600 µg vaccines 
caused a drop in plasma testosterone by the 
end of the study, although the 2-shot vaccine 
resulted in the greatest drop in testosterone.  
The reduction in testis weight was correlated 
with the drop in testosterone.  However, the 
single-shot vaccine was generally more 
effective in females than males.   
 We conclude that the GnRH vaccine 
has significant potential for use in limiting 
fertility of both males and females of many 
of domestic and wildlife species.  
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